カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

神経血管血栓除去装置の世界市場2022：機械的/断片化血栓除去装置、ステントレトリーバー、バスケット/ブラシレトリーバー、コイルレトリーバー、吸引血栓除去装置、流動性/流体力学的血栓除去装置、超音波血栓除去装置

◆英語タイトル：Global Neurovascular Thrombectomy Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
	◆商品コード：GIR22NO18075 ◆発行会社（リサーチ会社）：GlobalInfoResearch ◆発行日：2022年11月（※2025年版があります。お問い合わせください。） ◆ページ数：108 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（注文後2-3日） ◆調査対象地域：グローバル ◆産業分野：医療機器

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥528,960	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,220 ⇒換算￥793,440	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,057,920	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

神経血管血栓除去装置市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の神経血管血栓除去装置の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

神経血管血栓除去装置市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・機械的/断片化血栓除去装置、ステントレトリーバー、バスケット/ブラシレトリーバー、コイルレトリーバー、吸引血栓除去装置、流動性/流体力学的血栓除去装置、超音波血栓除去装置

用途別セグメントは次のように区分されます。
・病院・外科センター、外来外科センター、研究所・学術機関、その他

世界の神経血管血栓除去装置市場の主要な市場プレーヤーは以下のとおりです。
・Stryker Corporation (U.S.)、Medtronic plc (Ireland)、Boston Scientific Corporation (U.S.)、Johnson & Johnson (U.S.)、Terumo Corporation (Japan)、Penumbra, Inc. (U.S.)、Spectranetics Corporation (U.S.)、Edwards Lifesciences Corporation (U.S.)、Argon Medical Devices, Inc. (U.S.)、Teleflex Incorporated (U.S.)

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、神経血管血栓除去装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な神経血管血栓除去装置メーカーの企業概要、2019年～2022年までの神経血管血栓除去装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な神経血管血栓除去装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別神経血管血栓除去装置の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの神経血管血栓除去装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での神経血管血栓除去装置市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および神経血管血栓除去装置の産業チェーンを掲載しています。
・第13、14、15章では、神経血管血栓除去装置の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 神経血管血栓除去装置の概要
- 種類別分析（2017年vs2021年vs2028年）：機械的/断片化血栓除去装置、ステントレトリーバー、バスケット/ブラシレトリーバー、コイルレトリーバー、吸引血栓除去装置、流動性/流体力学的血栓除去装置、超音波血栓除去装置
- 用途別分析（2017年vs2021年vs2028年）：病院・外科センター、外来外科センター、研究所・学術機関、その他
- 世界の神経血管血栓除去装置市場規模・予測
- 世界の神経血管血栓除去装置生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Stryker Corporation (U.S.)、Medtronic plc (Ireland)、Boston Scientific Corporation (U.S.)、Johnson & Johnson (U.S.)、Terumo Corporation (Japan)、Penumbra, Inc. (U.S.)、Spectranetics Corporation (U.S.)、Edwards Lifesciences Corporation (U.S.)、Argon Medical Devices, Inc. (U.S.)、Teleflex Incorporated (U.S.)
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：機械的/断片化血栓除去装置、ステントレトリーバー、バスケット/ブラシレトリーバー、コイルレトリーバー、吸引血栓除去装置、流動性/流体力学的血栓除去装置、超音波血栓除去装置
・用途別分析2017年-2028年：病院・外科センター、外来外科センター、研究所・学術機関、その他
・神経血管血栓除去装置の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・神経血管血栓除去装置のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・神経血管血栓除去装置のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・神経血管血栓除去装置の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・神経血管血栓除去装置の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Neurovascular Thrombectomy Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Neurovascular Thrombectomy Device market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals and Surgical Centers accounting for % of the Neurovascular Thrombectomy Device global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Mechanical/Fragmentation Thrombectomy Devices segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Neurovascular Thrombectomy Device include Stryker Corporation (U.S.), Medtronic plc (Ireland), Boston Scientific Corporation (U.S.), Johnson & Johnson (U.S.), and Terumo Corporation (Japan), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Neurovascular Thrombectomy Device market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Mechanical/Fragmentation Thrombectomy Devices
Stent Retrievers
Basket/Brush Retrievers
Coil Retrievers
Aspiration Thrombectomy Devices
Rheolytic/Hydrodynamic Thrombectomy Devices
Ultrasonic Thrombectomy Devices
Market segment by Application can be divided into
Hospitals and Surgical Centers
Ambulatory Surgical Centers
Research Laboratories & Academic Institutes
Others
The key market players for global Neurovascular Thrombectomy Device market are listed below:
Stryker Corporation (U.S.)
Medtronic plc (Ireland)
Boston Scientific Corporation (U.S.)
Johnson & Johnson (U.S.)
Terumo Corporation (Japan)
Penumbra, Inc. (U.S.)
Spectranetics Corporation (U.S.)
Edwards Lifesciences Corporation (U.S.)
Argon Medical Devices, Inc. (U.S.)
Teleflex Incorporated (U.S.)
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neurovascular Thrombectomy Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Neurovascular Thrombectomy Device, with price, sales, revenue and global market share of Neurovascular Thrombectomy Device from 2019 to 2022.
Chapter 3, the Neurovascular Thrombectomy Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neurovascular Thrombectomy Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Neurovascular Thrombectomy Device market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Neurovascular Thrombectomy Device.
Chapter 13, 14, and 15, to describe Neurovascular Thrombectomy Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Neurovascular Thrombectomy Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Neurovascular Thrombectomy Device Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Mechanical/Fragmentation Thrombectomy Devices
1.2.3 Stent Retrievers
1.2.4 Basket/Brush Retrievers
1.2.5 Coil Retrievers
1.2.6 Aspiration Thrombectomy Devices
1.2.7 Rheolytic/Hydrodynamic Thrombectomy Devices
1.2.8 Ultrasonic Thrombectomy Devices
1.3 Market Analysis by Application
1.3.1 Overview: Global Neurovascular Thrombectomy Device Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals and Surgical Centers
1.3.3 Ambulatory Surgical Centers
1.3.4 Research Laboratories & Academic Institutes
1.3.5 Others
1.4 Global Neurovascular Thrombectomy Device Market Size & Forecast
1.4.1 Global Neurovascular Thrombectomy Device Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Neurovascular Thrombectomy Device Sales in Volume (2017-2028)
1.4.3 Global Neurovascular Thrombectomy Device Price (2017-2028)
1.5 Global Neurovascular Thrombectomy Device Production Capacity Analysis
1.5.1 Global Neurovascular Thrombectomy Device Total Production Capacity (2017-2028)
1.5.2 Global Neurovascular Thrombectomy Device Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Neurovascular Thrombectomy Device Market Drivers
1.6.2 Neurovascular Thrombectomy Device Market Restraints
1.6.3 Neurovascular Thrombectomy Device Trends Analysis
2 Manufacturers Profiles
2.1 Stryker Corporation (U.S.)
2.1.1 Stryker Corporation (U.S.) Details
2.1.2 Stryker Corporation (U.S.) Major Business
2.1.3 Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Product and Services
2.1.4 Stryker Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Medtronic plc (Ireland)
2.2.1 Medtronic plc (Ireland) Details
2.2.2 Medtronic plc (Ireland) Major Business
2.2.3 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Product and Services
2.2.4 Medtronic plc (Ireland) Neurovascular Thrombectomy Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Boston Scientific Corporation (U.S.)
2.3.1 Boston Scientific Corporation (U.S.) Details
2.3.2 Boston Scientific Corporation (U.S.) Major Business
2.3.3 Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Product and Services
2.3.4 Boston Scientific Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Johnson & Johnson (U.S.)
2.4.1 Johnson & Johnson (U.S.) Details
2.4.2 Johnson & Johnson (U.S.) Major Business
2.4.3 Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Product and Services
2.4.4 Johnson & Johnson (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Terumo Corporation (Japan)
2.5.1 Terumo Corporation (Japan) Details
2.5.2 Terumo Corporation (Japan) Major Business
2.5.3 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Product and Services
2.5.4 Terumo Corporation (Japan) Neurovascular Thrombectomy Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Penumbra, Inc. (U.S.)
2.6.1 Penumbra, Inc. (U.S.) Details
2.6.2 Penumbra, Inc. (U.S.) Major Business
2.6.3 Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Product and Services
2.6.4 Penumbra, Inc. (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Spectranetics Corporation (U.S.)
2.7.1 Spectranetics Corporation (U.S.) Details
2.7.2 Spectranetics Corporation (U.S.) Major Business
2.7.3 Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Product and Services
2.7.4 Spectranetics Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Edwards Lifesciences Corporation (U.S.)
2.8.1 Edwards Lifesciences Corporation (U.S.) Details
2.8.2 Edwards Lifesciences Corporation (U.S.) Major Business
2.8.3 Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Product and Services
2.8.4 Edwards Lifesciences Corporation (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Argon Medical Devices, Inc. (U.S.)
2.9.1 Argon Medical Devices, Inc. (U.S.) Details
2.9.2 Argon Medical Devices, Inc. (U.S.) Major Business
2.9.3 Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Product and Services
2.9.4 Argon Medical Devices, Inc. (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Teleflex Incorporated (U.S.)
2.10.1 Teleflex Incorporated (U.S.) Details
2.10.2 Teleflex Incorporated (U.S.) Major Business
2.10.3 Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Product and Services
2.10.4 Teleflex Incorporated (U.S.) Neurovascular Thrombectomy Device Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Neurovascular Thrombectomy Device Breakdown Data by Manufacturer
3.1 Global Neurovascular Thrombectomy Device Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Neurovascular Thrombectomy Device Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Neurovascular Thrombectomy Device
3.4 Market Concentration Rate
3.4.1 Top 3 Neurovascular Thrombectomy Device Manufacturer Market Share in 2021
3.4.2 Top 6 Neurovascular Thrombectomy Device Manufacturer Market Share in 2021
3.5 Global Neurovascular Thrombectomy Device Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Neurovascular Thrombectomy Device Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Neurovascular Thrombectomy Device Market Size by Region
4.1.1 Global Neurovascular Thrombectomy Device Sales in Volume by Region (2017-2028)
4.1.2 Global Neurovascular Thrombectomy Device Revenue by Region (2017-2028)
4.2 North America Neurovascular Thrombectomy Device Revenue (2017-2028)
4.3 Europe Neurovascular Thrombectomy Device Revenue (2017-2028)
4.4 Asia-Pacific Neurovascular Thrombectomy Device Revenue (2017-2028)
4.5 South America Neurovascular Thrombectomy Device Revenue (2017-2028)
4.6 Middle East and Africa Neurovascular Thrombectomy Device Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Neurovascular Thrombectomy Device Sales in Volume by Type (2017-2028)
5.2 Global Neurovascular Thrombectomy Device Revenue by Type (2017-2028)
5.3 Global Neurovascular Thrombectomy Device Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Neurovascular Thrombectomy Device Sales in Volume by Application (2017-2028)
6.2 Global Neurovascular Thrombectomy Device Revenue by Application (2017-2028)
6.3 Global Neurovascular Thrombectomy Device Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Neurovascular Thrombectomy Device Sales by Type (2017-2028)
7.2 North America Neurovascular Thrombectomy Device Sales by Application (2017-2028)
7.3 North America Neurovascular Thrombectomy Device Market Size by Country
7.3.1 North America Neurovascular Thrombectomy Device Sales in Volume by Country (2017-2028)
7.3.2 North America Neurovascular Thrombectomy Device Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Neurovascular Thrombectomy Device Sales by Type (2017-2028)
8.2 Europe Neurovascular Thrombectomy Device Sales by Application (2017-2028)
8.3 Europe Neurovascular Thrombectomy Device Market Size by Country
8.3.1 Europe Neurovascular Thrombectomy Device Sales in Volume by Country (2017-2028)
8.3.2 Europe Neurovascular Thrombectomy Device Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Neurovascular Thrombectomy Device Sales by Type (2017-2028)
9.2 Asia-Pacific Neurovascular Thrombectomy Device Sales by Application (2017-2028)
9.3 Asia-Pacific Neurovascular Thrombectomy Device Market Size by Region
9.3.1 Asia-Pacific Neurovascular Thrombectomy Device Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Neurovascular Thrombectomy Device Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Neurovascular Thrombectomy Device Sales by Type (2017-2028)
10.2 South America Neurovascular Thrombectomy Device Sales by Application (2017-2028)
10.3 South America Neurovascular Thrombectomy Device Market Size by Country
10.3.1 South America Neurovascular Thrombectomy Device Sales in Volume by Country (2017-2028)
10.3.2 South America Neurovascular Thrombectomy Device Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Neurovascular Thrombectomy Device Sales by Type (2017-2028)
11.2 Middle East & Africa Neurovascular Thrombectomy Device Sales by Application (2017-2028)
11.3 Middle East & Africa Neurovascular Thrombectomy Device Market Size by Country
11.3.1 Middle East & Africa Neurovascular Thrombectomy Device Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Neurovascular Thrombectomy Device Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Neurovascular Thrombectomy Device and Key Manufacturers
12.2 Manufacturing Costs Percentage of Neurovascular Thrombectomy Device
12.3 Neurovascular Thrombectomy Device Production Process
12.4 Neurovascular Thrombectomy Device Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Neurovascular Thrombectomy Device Typical Distributors
13.3 Neurovascular Thrombectomy Device Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 神経血管血栓除去装置の世界市場2022：機械的/断片化血栓除去装置、ステントレトリーバー、バスケット/ブラシレトリーバー、コイルレトリーバー、吸引血栓除去装置、流動性/流体力学的血栓除去装置、超音波血栓除去装置(Global Neurovascular Thrombectomy Device Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp